Beone Medicines Ltd. Class A · SSE:688235

Beone Medicines Ltd. Class A — Fact Sheet (February 2024)

3 slides from Beone Medicines Ltd. Class A's fact sheet, February 2024

1. Slide 1: Suzhou Manufacturing Campus

   Suzhou Manufacturing Campus Feb 2024 BeiGene Confidential

2. Slide 2: Multi-Functional Clinical & Commercial Manufacturing Facility

   Multi-Functional Clinical & Commercial Manufacturing Facility Global Quality Track Record > 30 Of Approvals and Inspections in 5+ Years (US FDA, EMA, China NMPA, ANVISA, TGA, MFDS, and more) Inspections with Zero Critical Observations Suzhou, China Site • *600M Capsule & Tablet Production Capacity O

3. Slide 3: BeiGene Global Manufacturing Capabilities Overview

   BeiGene Global Manufacturing Capabilities Overview Guangzhou, China Site | Clinical & Commercial Biologics production • DS Suite 4 with Single-use 500L, 2kL and Stainless 5kL Global Quality Drug • Batch and Fed-batch Track Record Substance • Mammalian (mAb, BsAb/TsAb, Fabs, Fusion, Recombinant prote

BeOne Medicines — Fact Sheet (February 2024) on 6ix